1. Treatment intensity and characteristics of MRSA infection in CF
Marianne S. Muhlebach, Meredith Miller, Lisa M. LaVange, Greg Mayhew, Jennifer S. Goodrich, Melissa B. Miller 
Journal of Cystic Fibrosis 
Volume 10, Issue 3, Pages (May 2011)
DOI: /j.jcf
Copyright © 2011 European Cystic Fibrosis Society. Terms and Conditions

2. Fig. 1
Longitudinal rate of change in FEV1% during the 2 years surrounding the infection with either MRSA (red) or MSSA (blue). Measurements obtained at 3-month intervals were compared for one year pre-infection to one year postinfection centered at the time of initial infection.
Journal of Cystic Fibrosis  , DOI: ( /j.jcf )
Copyright © 2011 European Cystic Fibrosis Society. Terms and Conditions

3. Fig. 2
Longitudinal change in FEV1 for MSSA (A) and MRSA (B) before and after acquisition of S. aureus acquisition. Analysis focuses on differences in rates of decline before and after S. aureus infection with an additional effect for change at the time of initial acquisition.
Journal of Cystic Fibrosis  , DOI: ( /j.jcf )
Copyright © 2011 European Cystic Fibrosis Society. Terms and Conditions